Corona vaccination Study is going on on the side effects of corona vaccines developed around the world. These include vaccines from AstraZeneca. A study of this vaccine, which has remained in the name of Covishield in India, has shown that it may have a slight risk of blood conditions due to platelet deficiency. However, it has not been reported as a serious problem. A study conducted in the UK states that there may be a problem of Idiopathic Thrombocytopenic Paralysis (ITP) per 10 million doses. Similar figures are also for the flu, smallpox, mums and rubella vaccines.
Already sick elderly may have some problem
This study states that Covishield may not show any symptoms of deficiency of platelets (blood cells that stop bleeding when there is damage to the arteries) but it can increase the risk of bleeding. In some cases, a blood clot may also form. According to a team of researchers from the University of Edinburgh, the risk of ITP may be more elderly. Especially people around the age of 70. That too to those people who already have heart disease, diabetes, chronic kidney disease. The researchers were unable to find a definite association between blood clotting and rare conditions such as cerebral venous sinus thrombosis, or CVST. This study was done on 54 lakh people of Scotland. Of these, 25 lakh people had taken the first dose of the vaccine.
Vaccines will now be available in private hospitals at this price, here are the rates fixed by the government
Analysts said, Kovishield very safe vaccine
However, analysts around the world say that the vaccines of Astra Zeneca (known as Covishield in India) do not have any serious health effects. This is a safe vaccine. Considering the possibility of such mild exposure in 10 million people, it can be called a very safe vaccine. People should definitely get vaccinated against Kovishield.